Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$26.60 USD
+1.20 (4.72%)
Updated May 9, 2024 04:00 PM ET
After-Market: $26.62 +0.02 (0.08%) 5:44 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Earnings News For CORT
-
Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
-
Corcept: Q1 Earnings Snapshot
-
Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow
-
Corcept: Q4 Earnings Snapshot
-
Why Is Corcept (CORT) Up 0.7% Since Last Earnings Report?
-
Corcept (CORT) Beats on Q3 Earnings, Raises '23 Sales View
-
Corcept: Q3 Earnings Snapshot
-
Corcept Therapeutics (CORT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Why Is Corcept (CORT) Up 4.8% Since Last Earnings Report?
-
Corcept (CORT) Beats on Q2 Earnings, Ups '23 Sales View
-
Corcept Therapeutics (CORT) Q2 Earnings and Revenues Surpass Estimates
-
Corcept: Q2 Earnings Snapshot
-
Analysts Estimate Corcept Therapeutics (CORT) to Report a Decline in Earnings: What to Look Out for
-
Corcept (CORT) Down 4.3% Since Last Earnings Report: Can It Rebound?
-
Corcept (CORT) Misses on Q1 Earnings, Revises 2023 Sales Guidance
-
Corcept Therapeutics (CORT) Lags Q1 Earnings Estimates
-
Corcept: Q1 Earnings Snapshot
-
Why Is Corcept (CORT) Up 9.6% Since Last Earnings Report?
-
Corcept's (CORT) Q4 Earnings and Revenues Miss Estimates
-
Corcept: Q4 Earnings Snapshot
-
Corcept Therapeutics (CORT) Lags Q4 Earnings and Revenue Estimates
-
Corcept's (CORT) Q3 Earnings Beat Estimates, Revenues Miss
-
Corcept Therapeutics (CORT) Tops Q3 Earnings Estimates
-
Corcept: Q3 Earnings Snapshot
-
Corcept (CORT) Down 8.3% Since Last Earnings Report: Can It Rebound?